Syneron Medical to Host Conference Call Today at 8:30 am ET to Discuss Global Joint Venture in Home Beauty Devices
YOKNEAM, Israel, Nov. 11, 2013 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company, today announced that it will host a conference call and a live webcast at 8:30 a.m. (ET) today, Monday, November 11, 2013, to discuss the Company's announcement earlier today of a definitive agreement to form a global joint venture in home beauty devices. A question & answer session will follow management's comments on the global joint venture.
Investors and analysts may participate in the conference call using the following dial-in numbers:
US (toll free): (877) 844-6886
International: (970) 315-0315
The conference passcode for both is 98561596.
The conference call will be broadcast live via the Investor Relations section of Syneron's website, www.investors.syneron.com. To access the call, enter the Syneron Investor Relations website, then click on the webcast link "Syneron Conference Call." Participants are encouraged to log on at least 15 minutes prior to the conference call in order to download the applicable audio software. Following the conclusion of the call, a replay of the webcast will be available within 24 hours on the Company's website.
About Syneron Medical Ltd.
Syneron Medical Ltd. (NASDAQ: ELOS) is the leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under two distinct brands, Syneron and Candela. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the US. The Company markets and services and supports its products in 90 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.
SOURCE Syneron Medical Ltd.